Influenza Clinical Trials in Nashville, Tennessee
5 recruitingNashville, Tennessee
Showing 1–5 of 5 trials
Recruiting
Phase 2
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
InfluenzaTransplantation InfectionImmunization; Infection
National Institute of Allergy and Infectious Diseases (NIAID)312 enrolled8 locationsNCT05947071
Recruiting
Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
InfluenzaTransplantation InfectionImmunization; Infection
Vanderbilt University Medical Center270 enrolled1 locationNCT05215327
Recruiting
Phase 2
High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)
InfluenzaImmunization; Infection|Transplantation Infection|Influenza
Vanderbilt University Medical Center60 enrolled1 locationNCT07192458
Recruiting
Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
COVID-19Lower Respiratory Tract InfectionImmunocompromised+1 more
Ansun Biopharma, Inc.274 enrolled67 locationsNCT03808922
Recruiting
Phase 1
Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of Age
Human MetapneumovirusHuman Parainfluenza Virus Type 3
National Institute of Allergy and Infectious Diseases (NIAID)25 enrolled4 locationsNCT06546423